Vandana Apte focuses on intellectual property matters, including patent law work for pharmaceutical and biotech companies. She first joined WilmerHale as a summer associate in 2022. 

Ms. Apte built her legal experience as a legal intern in the pharmaceutical industry, a student attorney at the Harvard Legal Aid Bureau in Massachusetts, and a legal intern at Pregnancy Justice in New York. She also has a wealth of technical experience, having worked as a systems genetics researcher at New York University Langone Health—where she designed an automated process for mass-testing COVID-19 patient samples—as well as at a genetics laboratory at the Waksman Institute of Microbiology at Rutgers University. She has also worked as a research assistant at multiple Harvard University Medical School labs and has co-authored two articles published in academic journals based on her research. 

Ms. Apte also maintains a strong pro bono practice, with a focus on reproductive rights and family defense.

Credentials

  • Education

    • JD, Harvard Law School, 2023

      Submissions Manager, Harvard Journal of Law and Technology

      Pro Bono Distinction for Completion of Over 1,000 Pro Bono Hours

    • BS, Biotechnology, Minor in Gender Studies, Rutgers University, 2017

      summa cum laude

      Fulbright Scholar, Barbara A. Zilinskas Award for Excellence in Biotechnology, Rutgers Presidential Scholar, George H. Cook Honors Thesis Scholar

  • Admissions

    • New York

    • New Jersey

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.